NDC 0409-1808 - Novocain

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 0409-1808
Package NDCs from labels: 0409-1808-02, 0409-1808-06
Manufacturer: Hospira, Inc.
Effective date: 2007-04-16
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
NOVOCAIN ® PROCAINE HYDROCHLORIDE INJECTION, USP	Hospira, Inc.	2007-04-16	Human prescription drug label

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0409-1808-02	Novocain	5 in 1 CONTAINER	INJECTION, SOLUTION	5	1
0409-1808-02	Novocain	40 in 1 CASE	INJECTION, SOLUTION	40	1
0409-1808-06	Novocain	50 in 1 TRAY	INJECTION, SOLUTION	50	1
0409-1808-06	Novocain	10 in 1 CASE	INJECTION, SOLUTION	10	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0409-1808	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1	4 package rows	20070426_C80C810A-60E0-49BD-139C-95AEC3A286FC.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Procaine Hydrochloride	ACTIVE INGREDIENT	95URV01IDQ	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Procaine	ACTIVE MOIETY	4Z8Y51M438	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Acetone Sodium Bisulfite	INACTIVE INGREDIENT		NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Chlorobutanol	INACTIVE INGREDIENT	HM4YQM8WRC	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Hydrochloric Acid	INACTIVE INGREDIENT	QTT17582CB	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Sodium Chloride	INACTIVE INGREDIENT	451W47IQ8X	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Sodium Hydroxide	INACTIVE INGREDIENT	55X04QC32I	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 12 of 13 · 253 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Sodium Chloride	SODIUM CHLORIDE	Fresenius Kabi USA, LLC	b6e33138-841a-471f-a934-c4086cbc23f6	2023-07-17	Warnings, Adverse reactions	Name fallback brand name: Sodium Chloride
rocuronium bromide	ROCURONIUM BROMIDE	Hospira, Inc.	c96726ef-f1fa-4ebb-ba33-3479c3902a8e	2023-06-06	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Naloxone Hydrochloride	NALOXONE HYDROCHLORIDE	Hospira, Inc.	b598c237-032d-4bb5-0e92-50eabd863dac	2023-06-04	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
BORTEZOMIB	BORTEZOMIB	Hospira, Inc.	9fdf6169-699f-40eb-bda1-760253062b3c	2023-02-27	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
SODIUM CHLORIDE	SODIUM CHLORIDE	Liebel-Flarsheim Company LLC	e4540d03-06b4-4b4d-b859-75c13e5c20dd	2022-12-20	Warnings, Adverse reactions	Name fallback brand name: SODIUM CHLORIDE
Sodium Chloride	SODIUM CHLORIDE	Baxter Healthcare Corporation	2fae04e3-20b1-4b8c-b1fb-646b384836f1	2022-12-07	Warnings, Adverse reactions	Name fallback brand name: Sodium Chloride
Sodium Chloride	SODIUM CHLORIDE	Fresenius Kabi USA, LLC	51da05ce-e3c4-4ef5-a845-dc869152e17f	2022-10-24	Warnings, Adverse reactions	Name fallback brand name: Sodium Chloride
Bleomycin	BLEOMYCIN	Hospira, Inc.	905e0984-2ce3-481c-b1a0-0ef0a616479a	2022-08-25	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Bleomycin	BLEOMYCIN	Hospira, Inc.	e629ba5a-4e08-4249-9551-af6dbd98a7e4	2022-08-25	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
SODIUM CHLORIDE	SODIUM CHLORIDE	Baxter Healthcare Corporation	123bd10a-90c7-499e-97f6-acf7e0f0fb4e	2022-07-29	Warnings, Adverse reactions	Name fallback brand name: SODIUM CHLORIDE
Milrinone Lactate in Dextrose	MILRINONE LACTATE IN DEXTROSE	Hospira, Inc.	5273ea17-6920-4bff-8c5b-20ea531a0423	2022-03-28	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Sodium Chloride	SODIUM CHLORIDE	B. Braun Medical Inc.	24a08a93-df23-474b-873e-c59ec8855f9f	2022-03-14	Warnings, Adverse reactions	Name fallback brand name: Sodium Chloride
Sodium Chloride	SODIUM CHLORIDE	B. Braun Medical Inc.	cc14fafd-3dcd-4fc8-bdbd-6f355c375768	2022-02-23	Warnings, Adverse reactions	Name fallback brand name: Sodium Chloride
Sodium Chloride	SODIUM CHLORIDE	Fresenius Kabi USA, LLC	8b44bfd3-70a4-4b47-bc7b-590f63b8cc75	2022-02-15	Warnings, Adverse reactions	Name fallback brand name: Sodium Chloride
Sodium Chloride	SODIUM CHLORIDE	Fresenius Kabi USA, LLC	f62481fd-fcdb-4be6-ac13-29c590e925c3	2022-02-10	Adverse reactions	Name fallback brand name: Sodium Chloride
Sodium Chloride	SODIUM CHLORIDE	B. Braun Medical Inc.	e44c41ae-c9c8-4dd8-ba6c-cebb585378aa	2022-01-31	Warnings, Adverse reactions	Name fallback brand name: Sodium Chloride
Sodium Chloride	SODIUM CHLORIDE	Fresenius Kabi USA, LLC	4829ee40-c2d7-4e17-a606-75e8a8628413	2021-12-21	Warnings, Adverse reactions	Name fallback brand name: Sodium Chloride
BUSULFAN	BUSULFAN	Hospira, Inc.	b9c7f0dc-988d-466e-8031-400ec4f60f21	2021-08-09	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Labetalol Hydrochloride	LABETALOL HYDROCHLORIDE	Hospira, Inc.	d3579d45-a964-40fe-e3a2-a3a997c8b7b9	2021-05-28	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Sodium Chloride	SODIUM CHLORIDE	Fresenius Kabi USA, LLC	4a655cde-283f-4ec8-a3d9-5f539c55c204	2021-05-10	Warnings, Adverse reactions	Name fallback brand name: Sodium Chloride

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.